Efficacy as a vector: the relative prevalence and paucity of inverse agonism.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Molecular Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/MOL.65.1.2PMID 14722230
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bombesin Analogues Inhibit Growth of Small Cell Lung Cancer in Vitro and in Vivo 1

  2006cited by this paper
• Antipsychotics with inverse agonist activity at the dopamine D3 receptor

  2005cited by this paper
• Ligand-selective receptor conformations revisited: the promise and the problem.

  2003cited by this paper
• Characteristics of recombinantly expressed rat and human histamine H3 receptors.

  2002cited by this paper
• Drug efficacy at G protein-coupled receptors.

  2002cited by this paper
• Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors

  2002cited by this paper
• Evidence for protean agonism of RX 831003 at α2A-adrenoceptors by co-expression with different Gα protein subunits

  2002cited by this paper
• Efficacy at g-protein-coupled receptors

  2002cited by this paper
• The ligand paradox between affinity and efficacy: can you be there and not make a difference?

  2002cited by this paper
• Constitutive Activity of the Human β1-Adrenergic Receptor in β1-Receptor Transgenic Mice

  2001cited by this paper
• Histamine H1-Receptor Activation of Nuclear Factor-κB: Roles for Gβγ- and Gαq/11-Subunits in Constitutive and Agonist-Mediated Signaling

  2001cited by this paper
• Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2.

  2001cited by this paper
• Constitutive activity of histamine h(3) receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H(3) antagonists.

  2001cited by this paper
• Agonist-, Antagonist-, and Inverse Agonist-Regulated Trafficking of the δ-Opioid Receptor Correlates with, but Does Not Require, G Protein Activation

  2001cited by this paper
• Inverse Agonist Activity at the α2A-Adrenergic Receptor

  2001cited by this paper
• Constitutive activity at serotonin 5-HT(1D) receptors: detection by homologous GTPgammaS versus [(35)S]-GTPgammaS binding isotherms.

  2001cited by this paper
• Agonist-, antagonist-, and inverse agonist-regulated trafficking of the delta-opioid receptor correlates with, but does not require, G protein activation.

  2001cited by this paper
• Inverse agonist up-regulates the constitutively active D3.49(164)Q mutant of the rat mu-opioid receptor by stabilizing the structure and blocking constitutive internalization and down-regulation.

  2001cited by this paper
• AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor.

  2001cited by this paper
• Inverse, protean, and ligand‐selective agonism: matters of receptor conformation

  2001cited by this paper
• BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity.

  2001cited by this paper
• Inverse agonist activity at the alpha(2A)-adrenergic receptor.

  2001cited by this paper
• Constitutive activity at serotonin 5-HT1D receptors: detection by homologous GTPγS versus [35S]-GTPγS binding isotherms

  2001cited by this paper
• Allosteric effects of G protein overexpression on the binding of beta-adrenergic ligands with distinct inverse efficacies.

  2001cited by this paper
• Inverse agonist activity of selected ligands of platelet-activating factor receptor.

  2001cited by this paper
• Inverse Agonist Properties of Antipsychotic Agents at Cloned, Human (h) Serotonin (5-HT)1B and h5-HT1D Receptors

  2001cited by this paper
• Constitutively Active μ-Opioid Receptors Inhibit Adenylyl Cyclase Activity in Intact Cells and Activate G-proteins Differently than the Agonist [d-Ala2,N-MePhe4,Gly-ol5]Enkephalin

  2001cited by this paper
• Functionally Different Agonists Induce Distinct Conformations in the G Protein Coupling Domain of the β2Adrenergic Receptor*

  2001cited by this paper
• A quantitative analysis of antagonism and inverse agonism at wild-type and constitutively active hamster α1B-adrenoceptors

  2000cited by this paper
• Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors.

  2000cited by this paper
• High constitutive activity of native H3 receptors regulates histamine neurons in brain

  2000cited by this paper
• Inverse agonism at alpha(2)-adrenoceptors in native tissue.

  2000cited by this paper
• The putative <<silent>> 5-HT(1A) receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT(1A) receptors.

  2000cited by this paper
• Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent.

  2000cited by this paper
• Potency of ligands correlates with affinity measured against agonist and inverse agonists but not against neutral ligand in constitutively active chemokine receptor.

  2000cited by this paper
• Chlorpropamide upregulates antidiuretic hormone receptors and unmasks constitutive receptor signaling.

  2000cited by this paper
• Inverse agonism and constitutive activity as functional correlates of serotonin h5-HT(1B) receptor/G-protein stoichiometry.

  2000cited by this paper
• Use of constitutive G protein-coupled receptor activity for drug discovery.

  2000cited by this paper
• 1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolytic agents.

  2000cited by this paper
• Regulation of the Cellular Localization and Signaling Properties of the α1B- and α1D-Adrenoceptors by Agonists and Inverse Agonists

  2000cited by this paper
• Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptor.

  2000cited by this paper
• Inverse agonism by Dmt-Tic analogues and HS 378, a naltrindole analogue.

  2000cited by this paper
• Pharmacological properties of 5-Hydroxytryptamine(4) receptor antagonists on constitutively active wild-type and mutated receptors.

  2000cited by this paper
• The Non-competitive Antagonists 2-Methyl-6-(phenylethynyl)pyridine and 7-Hydroxyiminocyclopropan[b]chromen-1a-carboxylic Acid Ethyl Ester Interact with Overlapping Binding Pockets in the Transmembrane Region of Group I Metabotropic Glutamate Receptors*

  2000cited by this paper
• Reconstitution of the human 5-HT(1D) receptor-G-protein coupling: evidence for constitutive activity and multiple receptor conformations.

  2000cited by this paper
• Constitutive activity of the histamine H(1) receptor reveals inverse agonism of histamine H(1) receptor antagonists.

  2000cited by this paper
• Inverse agonism and neutral antagonism at a constitutively active alpha‐1a adrenoceptor

  2000cited by this paper
• Inverse agonism at G protein‐coupled receptors: (patho)physiological relevance and implications for drug discovery

  2000cited by this paper
• 1-[2-[(Heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orally active 5-HT2C receptor inverse agonists.

  2000cited by this paper
• In various tumour cell lines the peptide bradykinin B2 receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist

  2000cited by this paper
• Inverse agonism at α2-adrenoceptors in native tissue

  2000cited by this paper
• A Look at Receptor Efficacy. From the Signalling Network of the Cell to the Intramolecular Motion of the Receptor

  2000cited by this paper
• Facilitation of Constitutive α2A-Adrenoceptor Activity by Both Single Amino Acid Mutation (Thr373Lys) and Gαo Protein Coexpression: Evidence for Inverse Agonism

  2000cited by this paper
• Regulation of the cellular localization and signaling properties of the alpha(1B)- and alpha(1D)-adrenoceptors by agonists and inverse agonists.

  2000cited by this paper
• Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528.

  1999cited by this paper
• (2S, 3R)TMT-L-Tic-OH is a potent inverse agonist at the human δ-opioid receptor

  1999cited by this paper
• SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist.

  1999cited by this paper
• Experimental study of the protein folding landscape: unfolding reactions in cytochrome c.

  1999cited by this paper
• Inverse Agonists and Serotonergic Transmission: From Recombinant, Human Serotonin (5-HT)1B Receptors to G-Protein Coupling and Function in Corticolimbic Structures in vivo

  1999cited by this paper
• Agonists and Inverse Agonists for the Herpesvirus 8-encoded Constitutively Active Seven-transmembrane Oncogene Product, ORF-74*

  1999cited by this paper
• Modulation of basal intracellular calcium by inverse agonists and phorbol myristate acetate in rat‐1 fibroblasts stably expressing α1d‐adrenoceptors

  1999cited by this paper
• Novel actions of inverse agonists on 5-HT2C receptor systems.

  1999cited by this paper
• Spontaneous Human B2 Bradykinin Receptor Activity Determines the Action of Partial Agonists as Agonists or Inverse Agonists

  1999cited by this paper
• Inverse agonist properties of dopaminergic antagonists at the D(1A) dopamine receptor: uncoupling of the D(1A) dopamine receptor from G(s) protein.

  1999cited by this paper
• Tight association of the human Mel(1a)-melatonin receptor and G(i): precoupling and constitutive activity.

  1999cited by this paper
• Inverse agonist abolishes desensitization of a constitutively active mutant of thyrotropin‐releasing hormone receptor: role of cellular calcium and protein kinase C

  1999cited by this paper
• Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalization cross-regulation.

  1999cited by this paper
• Agonist‐inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630

  1999cited by this paper
• Inverse Agonism and Neutral Antagonism at α1a- and α1b-Adrenergic Receptor Subtypes

  1999cited by this paper
• Constitutive receptor systems for drug discovery.

  1999cited by this paper
• Homologous regulation of the alpha2C-adrenoceptor subtype in human hepatocarcinoma, HepG2.

  1999cited by this paper
• Treatment with inverse agonists enhances baseline atrial contractility in transgenic mice with chronic beta2‐adrenoceptor activation

  1999cited by this paper
• Activation of constitutive 5-hydroxytryptamine(1B) receptor by a series of mutations in the BBXXB motif: positioning of the third intracellular loop distal junction and its G(o)alpha protein interactions.

  1999cited by this paper
• Efficacy of inverse agonists in cells overexpressing a constitutively active β2‐adrenoceptor and type II adenylyl cyclase

  1998cited by this paper
• Pharmacological Characterization of the Constitutively Activated State of the Serotonin 5‐HT2C Receptor

  1998cited by this paper
• The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo.

  1998cited by this paper
• The 5‐HT4 receptor antagonist ML10375 inhibits the constitutive activity of human 5‐HT4(c) receptor

  1998cited by this paper
• Pharmacological analysis of G‐protein activation mediated by guinea‐pig recombinant 5‐HT1B receptors in C6‐glial cells: similarities with the human 5‐HT1B receptor

  1998cited by this paper
• Functional characterisation of the human cloned 5‐HT7 receptor (long form); antagonist profile of SB‐258719

  1998cited by this paper
• 2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists.

  1998cited by this paper
• Exendin-(9-39) Is an Inverse Agonist of the Murine Glucagon-Like Peptide-1 Receptor: Implications for Basal Intracellular Cyclic Adenosine 3',5'-Monophosphate Levels and β-Cell Glucose Competence* *This work was supported by Grant 31-46958.96 from the Swiss National Science Foundation (to B.T.).

  1998cited by this paper
• Creation of a Constitutively Activated State of the 5‐HT2A Receptor by Site‐directed Mutagenesis: Revelation of Inverse Agonist Activity of Antagonists

  1998cited by this paper
• Agonist and Inverse Agonist Activity at the Dopamine D3 Receptor Measured by Guanosine 5′-[γ-Thio]Triphosphate-[35S] Binding

  1998cited by this paper
• Tiotidine, a classical H2-antagonist, presents characteristics of an inverse agonist in U937 cell line

  1998cited by this paper
• Human Interferon-γ–inducible Protein 10 (IP-10) Inhibits Constitutive Signaling of Kaposi's Sarcoma–associated Herpesvirus G Protein–coupled Receptor

  1998cited by this paper
• Inverse agonists and neutral antagonists of recombinant human A1 adenosine receptors stably expressed in Chinese hamster ovary cells.

  1998cited by this paper
• Protean Agonism at a 2A -Adrenoceptors

  1998cited by this paper
• Protean agonism at alpha2A-adrenoceptors.

  1998cited by this paper
• Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors

  1998cited by this paper
• Minor Modifications of a Cholecystokinin-B/Gastrin Receptor Non-peptide Antagonist Confer a Broad Spectrum of Functional Properties*

  1998cited by this paper
• Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs.

  1998cited by this paper
• AM630 is an inverse agonist at the human cannabinoid CB1 receptor.

  1998cited by this paper
• Exendin-(9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: implications for basal intracellular cyclic adenosine 3',5'-monophosphate levels and beta-cell glucose competence.

  1998cited by this paper
• High Constitutive Activity of the Human Formyl Peptide Receptor*

  1998cited by this paper
• The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities

  1998cited by this paper
• Deramciclane, a putative anxiolytic drug, is a serotonin 5-HT2C receptor inverse agonist but fails to induce 5-HT2C receptor down-regulation

  1998cited by this paper
• Agonist and inverse agonist efficacy at human recombinant serotonin 5-HT1A receptors as a function of receptor:G-protein stoichiometry.

  1997cited by this paper
• Pharmacology of muscarinic receptor subtypes constitutively activated by G proteins.

  1997cited by this paper
• Agonist Efficacy and Aliosteric Models of Receptor Action a

  1997cited by this paper
• Inverse agonism and the regulation of receptor number.

  1997cited by this paper

• Circadian Control of Sleep by Melatonin via MT1-Dependent Activation of BK Channels in the Suprachiasmatic Nucleus

  2025cites this paper
• Serotonin 2A (5-HT2A) receptor as evolving biological target: function, structure, ligands and role in the therapy of neuropsychiatric diseases.

  2025cites this paper
• Constitutive activity among orphan G protein-coupled receptors: Molecular mechanisms and pharmacological perspectives.

  2025cites this paper
• Adrenoceptors: Receptors, Ligands and Their Clinical Uses, Molecular Pharmacology and Assays.

  2024cites this paper
• Assay-Dependent Inverse Agonism at the A3 Adenosine Receptor: When Neutral Is Not Neutral.

  2023cites this paper
• Receptor density influences the recruitment bias of aripiprazole and brexpiprazole at the dopamine D2L receptor

  2022cites this paper
• In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl.

  2022cites this paper
• GABAB Receptor Chemistry and Pharmacology: Agonists, Antagonists, and Allosteric Modulators.

  2021cites this paper
• Label-Free Investigations on the G Protein Dependent Signaling Pathways of Histamine Receptors

  2021cites this paper
• Universality of the phenomenon of «neurotoxicity» (literature review)

  2021cites this paper
• OBSOLETE: Ion Channels

  2021cites this paper
• Kinetic Analysis of the Early Signaling Steps of the Human Chemokine Receptor CXCR4

  2020cites this paper
• Constitutive activity of 5-HT receptors: Factual analysis.

  2020cites this paper
• A Systematic Review of Inverse Agonism at Adrenoceptor Subtypes

  2020cites this paper
• A Dynamic, Split-Luciferase-Based Mini-G Protein Sensor to Functionally Characterize Ligands at All Four Histamine Receptor Subtypes

  2020cites this paper
• A physicochemical model of odor sampling

  2020cites this paper
• Delta Opioid Receptor Inverse Agonists and Their in vivo Pharmacological Effects.

  2020cites this paper
• Serotonin in eating behavior

  2020cites this paper
• Overcoming the psychiatric side effects of the cannabinoid CB1 receptor antagonists: Current approaches for therapeutics development.

  2019cites this paper
• The nature of efficacy at G protein-coupled receptors.

  2019cites this paper
• Biased Receptor Signaling in Drug Discovery

  2019cites this paper
• Applications and limitations of fitting of the operational model to determine relative efficacies of agonists

  2019cites this paper
• 5-HT2A Receptors in the Central Nervous System

  2018cites this paper
• Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity

  2018cites this paper
• Deciphering biased inverse agonism of cangrelor and ticagrelor at P2Y12 receptor

  2018cites this paper
• Pharmacological Analysis in Favour of a Physiological Role for the Constitutive Activity of 5-HT 2A Receptors in Learning

  2018cites this paper
• Ligand-selective small molecule modulators of the constitutively active vGPCR US28.

  2018cites this paper
• 18 – Basic Pharmacologic Principles

  2017cites this paper
• A Roadmap for Development of Novel Antipsychotic Agents Based on a Risperidone Scaffold

  2017cites this paper
• Metadichol ?®. A Novel Inverse Agonist of Aryl Hydrocarbon Receptor(AHR) and NRF2 Inhibitor

  2017cites this paper
• Synthesis and structure‐activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth

  2017cites this paper
• HUMANIZED ANTI CXCR 4 ANTIBODIES

  2017cites this paper
• Inverse agonists - What do they mean for psychiatry?

  2017cites this paper
• Pharmacological Characterization of Human Histamine Receptors and Histamine Receptor Mutants in the Sf9 Cell Expression System

  2017cites this paper
• Molecular Pharmacology of δ-Opioid Receptors

  2016cites this paper
• Design, synthesis, and biological evaluation of CXCR4 ligands.

  2016cites this paper
• Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor.

  2016cites this paper
• Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging.

  2016cites this paper
• Constitutive Desensitization of Opioid Receptors in Peripheral Sensory Neurons

  2016cites this paper
• Gaddum Memorial Lecture 2014: receptors as an evolving concept: from switches to biased microprocessors

  2015cites this paper
• The Independence of CXCR4’s Pathways, Gαi and β-Arrestin2, and Their Modulation by AMD3100 and TC14012

  2015cites this paper
• Auto‐inhibition at a ligand‐gated ion channel: a cross‐talk between orthosteric and allosteric sites

  2015cites this paper
• How Does the Brain Implement Adaptive Decision Making to Eat?

  2015cites this paper
• Maturational alterations in constitutive activity of medial prefrontal cortex kappa‐opioid receptors in Wistar rats

  2015cites this paper
• Discovery and characterization of an endogenous CXCR4 antagonist.

  2015cites this paper
• Atypical antipsychotics and inverse agonism at 5-HT2 receptors.

  2015cites this paper
• Receptors for Neuronal or Endocrine Signalling Molecules as Potential Targets for the Control of Insect Pests

  2014cites this paper
• A Comparison of Assay Performance Between the Calcium Mobilization and the Dynamic Mass Redistribution Technologies for the Human Urotensin Receptor

  2014cites this paper
• Constitutive activity in melanocortin-4 receptor: biased signaling of inverse agonists.

  2014cites this paper
• Allosteric modulation of the G protein-coupled US28 receptor of human cytomegalovirus: are the small-weight inverse agonist of US28 'camouflaged' agonists?

  2014cites this paper
• Constitutive activities in the thyrotropin receptor: regulation and significance.

  2014cites this paper
• Visualizing G protein-coupled receptors in action through confocal microscopy techniques.

  2014cites this paper
• Agonist‐dependent and ‐independent dopamine‐1‐like receptor signalling differentially regulates downstream effectors

  2014cites this paper
• Muscarinic toxins : characterization of adrenoceptor binding and applicability of membrane anchoring via glycosylphosphatidylinositol tail

  2014cites this paper
• Biased Agonism at G Protein‐Coupled Receptors: The Promise and the Challenges—A Medicinal Chemistry Perspective

  2014cites this paper
• Anesthetic Pharmacology: Pharmacodynamic principles of drug action

  2013cites this paper
• A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists

  2013cites this paper
• Radioligand binding and reporter gene assays for histamine H3 and H4 receptor species orthologs

  2013cites this paper
• Antihistaminergics and inverse agonism: potential therapeutic applications.

  2013cites this paper
• Current Cannabinoid Receptor Nomenclature and Pharmacological Principles

  2013cites this paper
• Antagonist of IL-1 Receptor Development of a Novel Noncompetitive

  2013cites this paper
• Mechanistic analysis of the function of agonists and allosteric modulators: reconciling two‐state and operational models

  2013cites this paper
• Inverse Agonist and Pharmacochaperone Properties of MK-0524 on the Prostanoid DP1 Receptor

  2013cites this paper
• Cannabinoid receptors: nomenclature and pharmacological principles.

  2012cites this paper
• Subtleties in GPCR drug discovery: a medicinal chemistry perspective.

  2012cites this paper
• Evidence for constitutively-active adenosine receptors at mammalian motor nerve endings.

  2012influential citation
• Synthesis and structure-affinity relationships of selective high-affinity 5-HT(4) receptor antagonists: application to the design of new potential single photon emission computed tomography tracers.

  2012cites this paper
• Molecular Pharmacology: Perspective Casting a Wider Net: Whole Cell Assays to Capture Varied and Biased Signaling

  2012cites this paper
• Mechanism of inverse agonist action of sarpogrelate at the constitutively active mutant of human 5-HT2A receptor revealed by molecular modeling.

  2012cites this paper
• Mechanism of N-terminal modulation of activity at the melanocortin-4 receptor GPCR.

  2012cites this paper
• Synthesis and Structure-Affinity Relationships of Selective High- Affinity 5-HT4 Receptor Antagonists: Application to the Design of New Potential Single Photon Emission Computed Tomography (SPECT) Tracers

  2012cites this paper
• Tonic Regulation of GABAergic Synaptic Activity on Vasopressin Neurones by Cannabinoids

  2012cites this paper
• Molecular Pharmacology: Perspective Casting a Wider Net: Whole Cell Assays to Capture Varied and Biased Signaling Cellular Assays Detect Pluridimensional and Biased Efficacy activity of ‘function sparing’ HIV-1 entry inhibitors on viral entry and CCR5

  2012cites this paper
• Muscarinic receptor agonists and antagonists: effects on cancer.

  2012cites this paper
• CB1 receptor antagonists: new discoveries leading to new perspectives

  2012cites this paper
• Fitting the complexity of GPCRs modulation into simple hypotheses of ligand design.

  2012cites this paper
• Casting a Wider Net: Whole-Cell Assays to Capture Varied and Biased Signaling

  2012cites this paper
• Identification of novel allosteric modulators for the G-protein coupled US28 receptor of human cytomegalovirus.

  2011cites this paper
• The design, synthesis and pharmacological characterization of novel β2‐adrenoceptor antagonists

  2011cites this paper
• Human β 1 -adrenergic receptor : biosynthesis, processing and the carboxyl-terminal polymorphism

  2011influential citation
• Exploring the structure, function & regulation of the human glucagon-like peptide-1 receptor

  2011cites this paper
• Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.

  2011cites this paper
• The Constitutive Activity of 5-HT2C Receptors as an Additional Modality of Interaction of the Serotonergic System

  2011cites this paper
• Rimonabant Redux and Strategies to Improve the Future Outlook of CB1 Receptor Neutral‐Antagonist/Inverse‐Agonist Therapies

  2011cites this paper
• Ligand-binding domain subregions contributing to bimodal agonism in cyclic nucleotide–gated channels

  2011cites this paper
• Ligand functional selectivity and quantitative pharmacology at G protein-coupled receptors

  2011cites this paper
• Functional Selectivity and Biased Receptor Signaling

  2011cites this paper
• Constitutive activity of the histamine H(1) receptor.

  2010cites this paper
• Signal Transduction: Pathways, Mechanisms and Diseases

  2010cites this paper
• Use of the GTP g S ( [ 35 S ] GTP g S and Eu-GTP g S ) binding assay for analysis of ligand potency and efficacy at G protein-coupled receptors

  2010cites this paper
• Development of a GPR23 cell-based β-lactamase reporter assay.

  2010cites this paper
• Non-invasive imaging of the type 2 cannabinoid receptor, focus on positron emission tomography.

  2010cites this paper
• The Constitutive Activity of the Human Muscarinic M3 Receptor Unmasks Differences in the Pharmacology of Anticholinergics

  2010cites this paper
• 5-hydroxytryptamine subtype 6 receptor modulators: a patent survey

  2010cites this paper
• How inverse can a neutral antagonist be? Strategic questions after the rimonabant issue.

  2010cites this paper
• Identification of a novel “almost neutral” μ‐opioid receptor antagonist in CHO cells expressing the cloned human μ‐opioid receptor

  2010influential citation
• 5-HT6 receptor signal transduction second messenger systems.

  2010cites this paper
• The GTPase assay as a highly sensitive model system for characterization of human cannabinoid receptors and their ligands. G alpha i2 co-expression and fusion studies and the impact of RGS proteins

  2010cites this paper
• JPET #173948 PIP Perspectives in Pharmacology Functional Selectivity and Biased Receptor Signaling

  2010cites this paper
• α(1D)-Adrenergic receptors constitutive activity and reduced expression at the plasma membrane.

  2010cites this paper